Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Org chart
Collapse
Teams
This company has no teams yet
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
This company has no teams yet
